Department of Surgery, Shouldice Hospital, 7750 Bayview Ave., Thornhill, ON, L3T 4A3, Canada.
UZIK Consulting Inc., Toronto, Canada.
Hernia. 2024 Oct;28(5):1849-1854. doi: 10.1007/s10029-024-03101-0. Epub 2024 Aug 2.
There is limited research on the impact of an ilioinguinal-iliohypogastric nerve block on intraoperative opioid consumption when conducting groin hernia repair in adults. Thus, the aim was to evaluate ilioinguinal-iliohypogastric nerve block for groin hernia patients at Shouldice Hospital.
The study was a pilot retrospective chart review on patients who underwent a Shouldice Repair from November 2023 to December 2023. This study compared individuals receiving an ilioinguinal-iliohypogastric nerve block with local anesthesia and fentanyl analgesia to those who received local anesthesia and fentanyl analgesia, by manually matching 1:1 on 12 demographic and intraoperative characteristics. Comparison between groups was performed using chi-square/Fisher Exact test for categorical and t-test/Mann-Whitney test for numerical variables depending on data distribution. Multivariable regression analysis was used to examine predictors of intraoperative use of fentanyl.
In this study 50 matched pairs of unilateral primary inguinal hernia patients were analyzed. The ilioinguinal-iliohypogastric nerve block patients had lower recorded intraoperative fentanyl (85mcg less than control, p < .001) and dimenhydrinate (13 mg less than control, p < .001) than the control group patients. No differences were found in postoperative day 0 to 3 for acetaminophen, non-steroidal anti-inflammatory drug, and opioid consumption between the patients who did receive an ilioinguinal-iliohypogastric nerve block prior to surgery and those that did not.
The administration of an ilioinguinal-iliohypogastric nerve block prior to primary inguinal hernia repair using a Shouldice Repair is associated with a significantly lower intraoperative fentanyl consumption compared to non-administration.
在成人腹股沟疝修补术中,关于髂腹下-髂腹股沟神经阻滞对术中阿片类药物消耗的影响的研究有限。因此,本研究旨在评估 Shouldice 医院行腹股沟疝修补术的患者行髂腹下-髂腹股沟神经阻滞的效果。
这是一项在 2023 年 11 月至 2023 年 12 月期间接受 Shouldice 修复术的患者的试点回顾性图表研究。本研究通过手动匹配 1:1 的 12 项人口统计学和术中特征,比较了接受髂腹下-髂腹股沟神经阻滞联合局部麻醉和芬太尼镇痛的患者与接受局部麻醉和芬太尼镇痛的患者。组间比较采用卡方/Fisher 精确检验进行分类变量比较,采用 t 检验/Mann-Whitney 检验进行数值变量比较,具体取决于数据分布。采用多变量回归分析来检验术中使用芬太尼的预测因素。
本研究分析了 50 对单侧原发性腹股沟疝患者的匹配对。与对照组相比,接受髂腹下-髂腹股沟神经阻滞的患者术中芬太尼(少 85mcg,p<0.001)和茶苯海明(少 13mg,p<0.001)的记录量较低。在术后第 0 天至第 3 天,接受髂腹下-髂腹股沟神经阻滞的患者与未接受该阻滞的患者相比,对乙酰氨基酚、非甾体抗炎药和阿片类药物的消耗量无差异。
与未行该阻滞相比,在使用 Shouldice 修复术行原发性腹股沟疝修补术前给予髂腹下-髂腹股沟神经阻滞与术中芬太尼消耗显著降低相关。